Johnson and Johnson Loses Key Tuberculosis Drug Patent In India

The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.

Related Keywords

Mumbai ,Maharashtra ,India ,South Africa ,United States ,South African ,Phumeza Tisile ,Ilaria Motta ,Latika Dawara ,Nandita Venkatesan ,Tb Partnership ,Indian Patent Office On ,Access Campaign ,World Health Organization ,Indian Patent Office ,South African Phumeza Tisile ,Designs Latika Dawara ,Doctors Without Borders ,Johnson Amp ,Tuberculosis ,Bedaquiline ,